154 related articles for article (PubMed ID: 22940073)
1. Accelerated axonal loss following acute CNS demyelination in mice lacking protein tyrosine phosphatase receptor type Z.
Huang JK; Ferrari CC; Monteiro de Castro G; Lafont D; Zhao C; Zaratin P; Pouly S; Greco B; Franklin RJ
Am J Pathol; 2012 Nov; 181(5):1518-23. PubMed ID: 22940073
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of Protein Tyrosine Phosphatase Receptor Type Z by Pleiotrophin Promotes Remyelination through Activation of Differentiation of Oligodendrocyte Precursor Cells.
Kuboyama K; Fujikawa A; Suzuki R; Noda M
J Neurosci; 2015 Sep; 35(35):12162-71. PubMed ID: 26338327
[TBL] [Abstract][Full Text] [Related]
3. Protein tyrosine phosphatase receptor type z negatively regulates oligodendrocyte differentiation and myelination.
Kuboyama K; Fujikawa A; Masumura M; Suzuki R; Matsumoto M; Noda M
PLoS One; 2012; 7(11):e48797. PubMed ID: 23144976
[TBL] [Abstract][Full Text] [Related]
4. Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination.
Harrington EP; Zhao C; Fancy SP; Kaing S; Franklin RJ; Rowitch DH
Ann Neurol; 2010 Nov; 68(5):703-16. PubMed ID: 20853437
[TBL] [Abstract][Full Text] [Related]
5. The PTN-PTPRZ signal activates the AFAP1L2-dependent PI3K-AKT pathway for oligodendrocyte differentiation: Targeted inactivation of PTPRZ activity in mice.
Tanga N; Kuboyama K; Kishimoto A; Kiyonari H; Shiraishi A; Suzuki R; Watanabe T; Fujikawa A; Noda M
Glia; 2019 May; 67(5):967-984. PubMed ID: 30667096
[TBL] [Abstract][Full Text] [Related]
6. A critical role for the protein tyrosine phosphatase receptor type Z in functional recovery from demyelinating lesions.
Harroch S; Furtado GC; Brueck W; Rosenbluth J; Lafaille J; Chao M; Buxbaum JD; Schlessinger J
Nat Genet; 2002 Nov; 32(3):411-4. PubMed ID: 12355066
[TBL] [Abstract][Full Text] [Related]
7. Acid sphingomyelinase deficiency enhances myelin repair after acute and chronic demyelination.
Chami M; Halmer R; Schnoeder L; Anne Becker K; Meier C; Fassbender K; Gulbins E; Walter S
PLoS One; 2017; 12(6):e0178622. PubMed ID: 28582448
[TBL] [Abstract][Full Text] [Related]
8. Chronic toxic demyelination in the central nervous system leads to axonal damage despite remyelination.
Lindner M; Fokuhl J; Linsmeier F; Trebst C; Stangel M
Neurosci Lett; 2009 Apr; 453(2):120-5. PubMed ID: 19356606
[TBL] [Abstract][Full Text] [Related]
9. Role of Chondroitin Sulfate (CS) Modification in the Regulation of Protein-tyrosine Phosphatase Receptor Type Z (PTPRZ) Activity: PLEIOTROPHIN-PTPRZ-A SIGNALING IS INVOLVED IN OLIGODENDROCYTE DIFFERENTIATION.
Kuboyama K; Fujikawa A; Suzuki R; Tanga N; Noda M
J Biol Chem; 2016 Aug; 291(35):18117-28. PubMed ID: 27445335
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial DNA Double-Strand Breaks in Oligodendrocytes Cause Demyelination, Axonal Injury, and CNS Inflammation.
Madsen PM; Pinto M; Patel S; McCarthy S; Gao H; Taherian M; Karmally S; Pereira CV; Dvoriantchikova G; Ivanov D; Tanaka KF; Moraes CT; Brambilla R
J Neurosci; 2017 Oct; 37(42):10185-10199. PubMed ID: 28931570
[TBL] [Abstract][Full Text] [Related]
11. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
12. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination.
McLane LE; Bourne JN; Evangelou AV; Khandker L; Macklin WB; Wood TL
J Neurosci; 2017 Aug; 37(31):7534-7546. PubMed ID: 28694334
[TBL] [Abstract][Full Text] [Related]
13. A complex between contactin-1 and the protein tyrosine phosphatase PTPRZ controls the development of oligodendrocyte precursor cells.
Lamprianou S; Chatzopoulou E; Thomas JL; Bouyain S; Harroch S
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17498-503. PubMed ID: 21969550
[TBL] [Abstract][Full Text] [Related]
14. Loss of branched O-mannosyl glycans in astrocytes accelerates remyelination.
Kanekiyo K; Inamori K; Kitazume S; Sato K; Maeda J; Higuchi M; Kizuka Y; Korekane H; Matsuo I; Honke K; Taniguchi N
J Neurosci; 2013 Jun; 33(24):10037-47. PubMed ID: 23761899
[TBL] [Abstract][Full Text] [Related]
15. Changes in the distribution of a calcium-dependent ATPase during demyelination and remyelination in the central nervous system.
Felts PA; Smith KJ
J Neurocytol; 1996 Mar; 25(3):171-80. PubMed ID: 8737170
[TBL] [Abstract][Full Text] [Related]
16. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation.
Garbern JY; Yool DA; Moore GJ; Wilds IB; Faulk MW; Klugmann M; Nave KA; Sistermans EA; van der Knaap MS; Bird TD; Shy ME; Kamholz JA; Griffiths IR
Brain; 2002 Mar; 125(Pt 3):551-61. PubMed ID: 11872612
[TBL] [Abstract][Full Text] [Related]
17. Experimental Demyelination and Axonal Loss Are Reduced in MicroRNA-146a Deficient Mice.
Martin NA; Molnar V; Szilagyi GT; Elkjaer ML; Nawrocki A; Okarmus J; Wlodarczyk A; Thygesen EK; Palkovits M; Gallyas F; Larsen MR; Lassmann H; Benedikz E; Owens T; Svenningsen AF; Illes Z
Front Immunol; 2018; 9():490. PubMed ID: 29593734
[TBL] [Abstract][Full Text] [Related]
18. Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin.
Wang C; Kotter MR
Methods Mol Biol; 2018; 1791():233-241. PubMed ID: 30006714
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of spinal cord demyelination, remyelination, atrophy, and axonal loss in a model of progressive neurologic injury.
McGavern DB; Murray PD; Rodriguez M
J Neurosci Res; 1999 Nov; 58(4):492-504. PubMed ID: 10533042
[TBL] [Abstract][Full Text] [Related]
20. Activity of a newly identified serine protease in CNS demyelination.
Scarisbrick IA; Blaber SI; Lucchinetti CF; Genain CP; Blaber M; Rodriguez M
Brain; 2002 Jun; 125(Pt 6):1283-96. PubMed ID: 12023317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
